Teicoplanin and daptomycin bactericidal activities in the presence of albumin or serum under controlled conditions of pH and ionized calcium
Open Access
- 1 March 1993
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 37 (3) , 605-609
- https://doi.org/10.1128/aac.37.3.605
Abstract
Teicoplanin and daptomycin bactericidal rates (BRs) were measured from standard kill curves in supplemented Mueller-Hinton broth (B), B with 3 g of albumin per dl (BA), B with 50% pooled human serum (BS), and in broth to simulate free concentrations (BF) under controlled physiologic conditions of pH (7.4) and ionized calcium (1.15 to 1.17 mM) against two clinical Staphylococcus aureus strains. Total concentrations of teicoplanin and daptomycin, respectively, were 45 and 12.5 micrograms/ml in B, BA, and BS and 4.5 and 1.25 micrograms/ml in BF. All BRs are reported as log10 CFU per milliliter per hour. There was a trend for the teicoplanin BR to be inhibited by serum for strain 67 (BR in B was -0.26 +/- 0.08 versus a BR in BS of -0.19 +/- 0.08 [P > 0.05]). The teicoplanin BRs for strain 135 were unaffected by the type of medium used (range, -0.17 to -0.20). For both strains, daptomycin BRs were adversely affected by lower concentrations, albumin, and serum. The BR of daptomycin was significantly faster in B (-4.53 +/- 1.92) (P < 0.05) than it was in BF (-0.58 +/- 0.04), BA (-1.68 +/- 0.28), or BS (-1.02 +/- 0.16) against strain 67. BA and BS resulted in BRs more than twice that in BF (P > 0.05). Against strain 135, daptomycin again produced the highest BR in B; however, the BRs in BF, BA, and BS were almost identical, indicating that only free daptomycin was active. After correcting for the influence of protein binding, pH, and ionized calcium, teicoplanin appeared to be inhibited by serum, and daptomycin demonstrated enhanced BRs against different S. aureus strains in the presence of albumin or serum.Keywords
This publication has 23 references indexed in Scilit:
- Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteersAntimicrobial Agents and Chemotherapy, 1992
- Comparative effect of protein binding on the killing activities of teicoplanin and vancomycinAntimicrobial Agents and Chemotherapy, 1991
- Synergistic Bactericidal Activity of Rat Serum with Vancomycin against EnterococciThe Journal of Infectious Diseases, 1991
- Influence of subinhibitory concentrations of loracarbef (LY 163892) and daptomycin (LY 146032) on bacterial phagocytosis, killing and serum sensitivityJournal of Antimicrobial Chemotherapy, 1990
- Influence of Subinhibitory Concentrations of Cephalosporins on the Serum Sensitivity of Pseudomonas aeruginosaThe Journal of Infectious Diseases, 1990
- Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studiesDiagnostic Microbiology and Infectious Disease, 1990
- In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1989
- Comparison of in vitro Activity of Daptomycin, Vancomycin and Fluoroquinolones in Broth and Serum against Staphylococcus epidermidisas Determined by Time-Kill KineticsChemotherapy, 1989
- LY146032: activity and resistance development in vitroJournal of Antimicrobial Chemotherapy, 1987
- Serum Dilution Test for Bactericidal Activity. II. Standardization and Correlation with Antimicrobial Assays and Susceptibility TestsThe Journal of Infectious Diseases, 1977